ad image

BioVectra and PhaseBio Discuss Creating an Optimal Partnership

D
David Alvaro, Ph.D.

Editor in Chief

Pharma's Almanac

J
Jonathan Mow

Chief Executive Officer

O
Oliver Technow

Chief Executive Officer

BIOVECTRA

Apr 15, 2021PTV-04-21-CL-001
CDMOStrategic PartnerPA TVBIOVECTRACardiovascularBiologics ManufacturingLarge MoleculeSupply AgreementPhaseBioQ22021

BioVectra's Oliver Technow and PhaseBio's Jonathan Mow discuss their new supply agreement and the essential elements for an effective partnership.

ad image
ad image